Skip to main content

Table 4 Univariate and multivariate Cox proportional hazards regression for recurrence-free and overall survival

From: Pathological complete response to neoadjuvant chemotherapy in triple negative breast cancer – single hospital experience

Covariate

Univariate analysis

Multivariate analysis

HR

95% CI

p

HR

95% CI

p

Recurrence-free survival

 cT

2.46

1.39–4.33

0.0033

1.43

0.70–2.89

0.3620

 cN

2.89

1.49–5.60

0.0016

2.25

1.03–4.92

0.0423

 ypT

2.14

1.33–3.43

0.0025

1.68

0.91–3.09

0.0940

 ypN

1.95

1.20–3.18

0.0171

0.77

0.37–1.59

0.4880

 BRCA

0.79

0.25–2.49

0.6952

   

 pCR

0.34

0.07–1.45

0.0971

   

 Platinum-based NAC

1.15

0.41–3.24

0.7852

   

 Ki67 group

0.51

0.17–1.48

0.2056

   

 Age group

1.49

0.71–3.13

0.2803

   

Overall survival

 cT

2.20

1.09–4.44

0.0274

0.73

0.25–2.14

0.5698

 cN

2.02

1.17–3.48

0.0123

3.42

1.00–11.62

0.0502

 ypT

1.86

1.05–3.32

0.0349

1.27

0.53–3.05

0.5919

 ypN

2.16

1.21–3.84

0.0091

0.90

0.40–2.81

0.4996

 BRCA

0.77

0.16–3.72

0.7487

   

 pCR

0.36

0.04–2.94

0.3484

   

 Platinum-based NAC

7.02

0.88–55.62

0.0213

7.52

0.75–70.04

0.0885

 Ki67 group

0.58

0.14–2.30

0.4283

   

 Age group

1.20

0.47–3.08

0.6995